• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏磁共振钆延迟增强与肥厚型心肌病的表型表达。

Late gadolinium enhancement on cardiac magnetic resonance and phenotypic expression in hypertrophic cardiomyopathy.

机构信息

Ospedale Mauriziano, Torino, Italy.

出版信息

Am Heart J. 2011 Jun;161(6):1073-7. doi: 10.1016/j.ahj.2011.03.022.

DOI:10.1016/j.ahj.2011.03.022
PMID:21641353
Abstract

BACKGROUND

Cardiac magnetic resonance (CMR) imaging with late gadolinium enhancement (LGE) can identify areas of myocardial fibrosis in vivo in patients with hypertrophic cardiomyopathy (HCM). The aim of this study was to examine the association between clinical-morphological variables, risk factor for sudden death, and LGE findings in a consecutive, unselected population of HCM patients.

METHODS

From January 2005 to August 2009, 124 HCM patients (53 ± 17 years, 86 men) were prospectively evaluated with CMR examination, assessing left ventricular (LV) hypertrophy, function, and LGE.

RESULTS

In univariate analysis, patients were divided into tertiles according to the number of segments positive for LGE (first tertile, 0.3 ± 0.4; second tertile, 2.2 ± 0.4; third tertile, 5.2 ± 1.9 segments). Male gender (P = .05), maximum LV wall thickness (P = .002), nonsustained ventricular tachycardia (P = .001), ejection fraction <50% (P = .02), LV mass (P = .02), left atrium dilation (P = .04), perfusion defects (P ≤ .001), and telesystolic volume (P = .04) were all positively related with the number of segments of LGE. In multivariable analysis, male gender (P = .007), maximum LV wall thickness (P = .006), LV mass (P = .031), and perfusion alterations (P = .017) were independent predictors of LGE extent.

CONCLUSIONS

Our study shows an independent association, even at multivariate analysis, between the entity of LGE and maximum LV wall thickness, mass, and perfusion defects in patients with HCM. Whether the presence and the extent of LGE translates into clinical events later on awaits further long-term follow-up studies.

摘要

背景

心脏磁共振(CMR)成像与晚期钆增强(LGE)可在肥厚型心肌病(HCM)患者体内活体识别心肌纤维化区域。本研究旨在检查连续、未经选择的 HCM 患者人群中临床形态学变量、猝死危险因素与 LGE 结果之间的相关性。

方法

从 2005 年 1 月至 2009 年 8 月,前瞻性评估了 124 例 HCM 患者(53±17 岁,86 名男性)的 CMR 检查,评估左心室(LV)肥厚、功能和 LGE。

结果

在单变量分析中,根据 LGE 阳性节段数将患者分为三组(第一组,0.3±0.4;第二组,2.2±0.4;第三组,5.2±1.9 个节段)。男性(P=0.05)、最大 LV 壁厚度(P=0.002)、非持续性室性心动过速(P=0.001)、射血分数<50%(P=0.02)、LV 质量(P=0.02)、左心房扩张(P=0.04)、灌注缺陷(P≤0.001)和收缩期前容积(P=0.04)均与 LGE 节段数呈正相关。在多变量分析中,男性(P=0.007)、最大 LV 壁厚度(P=0.006)、LV 质量(P=0.031)和灌注改变(P=0.017)是 LGE 程度的独立预测因素。

结论

我们的研究表明,即使在多变量分析中,LGE 的存在和程度与 HCM 患者的最大 LV 壁厚度、质量和灌注缺陷也有独立的相关性。LGE 的存在和程度是否会转化为以后的临床事件,还需要进一步的长期随访研究。

相似文献

1
Late gadolinium enhancement on cardiac magnetic resonance and phenotypic expression in hypertrophic cardiomyopathy.心脏磁共振钆延迟增强与肥厚型心肌病的表型表达。
Am Heart J. 2011 Jun;161(6):1073-7. doi: 10.1016/j.ahj.2011.03.022.
2
Phenotypic expression in hypertrophic cardiomyopathy and late gadolinium enhancement on cardiac magnetic resonance.肥厚型心肌病的表型表达与心脏磁共振延迟钆增强
Rev Port Cardiol. 2014 May;33(5):261-7. doi: 10.1016/j.repc.2013.10.005. Epub 2014 Jun 6.
3
[Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].[钆延迟强化在肥厚型心肌病患者心血管磁共振成像中的临床意义]
Rev Esp Cardiol. 2007 Jan;60(1):15-23.
4
The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.肥厚型心肌病患者延迟钆增强磁共振与非持续室性心动过速负荷的关系:一项延迟对比增强磁共振研究。
J Cardiovasc Electrophysiol. 2019 May;30(5):651-657. doi: 10.1111/jce.13855. Epub 2019 Feb 2.
5
Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.应用三维斑点追踪超声心动图研究心肌整体和局部力学与肥厚型心肌病心肌肥厚和纤维化的关系。
Circ Cardiovasc Imaging. 2014 Jan;7(1):11-9. doi: 10.1161/CIRCIMAGING.113.000842. Epub 2013 Nov 25.
6
Late gadolinium enhancement is common in patients with hypertrophic cardiomyopathy and no clinical risk factors for sudden cardiac death: A single center experience.晚期钆增强在肥厚型心肌病且无心脏性猝死临床危险因素的患者中很常见:一项单中心经验。
Cardiol J. 2014;21(1):29-32. doi: 10.5603/CJ.a2013.0115. Epub 2013 Aug 30.
7
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.定量对比增强心血管磁共振对肥厚型心肌病患者猝死风险评估的预后价值。
Circulation. 2014 Aug 5;130(6):484-95. doi: 10.1161/CIRCULATIONAHA.113.007094.
8
Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者对比增强磁共振成像延迟钆增强的特征及临床意义。
Circ Heart Fail. 2010 Jan;3(1):51-8. doi: 10.1161/CIRCHEARTFAILURE.109.854026. Epub 2009 Oct 22.
9
Association of Late Gadolinium Enhancement and Degree of Left Ventricular Hypertrophy Assessed on Cardiac Magnetic Resonance Imaging With Ventricular Tachycardia in Children With Hypertrophic Cardiomyopathy.肥厚型心肌病患儿心脏磁共振成像评估的晚期钆增强与左心室肥厚程度与室性心动过速的关联。
Am J Cardiol. 2016 Apr 15;117(8):1342-8. doi: 10.1016/j.amjcard.2016.01.032. Epub 2016 Jan 28.
10
Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.肥厚型心肌病中心肌磁共振成像显示的心肌纤维化进展
Heart. 2015 Jun;101(11):870-6. doi: 10.1136/heartjnl-2014-306555. Epub 2015 Apr 20.

引用本文的文献

1
Understanding Sex Differences in Hypertrophic Cardiomyopathy Surgery: Insights From a Decade-Long Cohort Study From China.了解肥厚型心肌病手术中的性别差异:来自中国一项长达十年队列研究的见解
J Am Heart Assoc. 2025 Mar 4;14(5):e038421. doi: 10.1161/JAHA.124.038421. Epub 2025 Feb 25.
2
High altitudes, deeper insights: multicenter cardiovascular magnetic resonance study on hypertrophic cardiomyopathy.高海拔地区,深入洞察:肥厚型心肌病的多中心心血管磁共振研究
Eur Radiol. 2024 Dec 31. doi: 10.1007/s00330-024-11305-2.
3
Preoperative myocardial fibrosis is associated with worse survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: A delayed enhanced cardiac magnetic resonance study.
术前心肌纤维化与肥厚型梗阻性心肌病患者酒精间隔消融术后较差的生存率相关:一项延迟强化心脏磁共振研究。
Front Cardiovasc Med. 2022 Aug 11;9:924804. doi: 10.3389/fcvm.2022.924804. eCollection 2022.
4
Sex-related differences in left ventricular remodeling and outcome after alcohol septal ablation in hypertrophic obstructive cardiomyopathy: insights from cardiovascular magnetic resonance imaging.性别差异对肥厚型梗阻性心肌病酒精室间隔消融术后左心室重构和结局的影响:心血管磁共振成像的见解。
Biol Sex Differ. 2022 Jul 7;13(1):37. doi: 10.1186/s13293-022-00447-x.
5
Machine learning phenotyping of scarred myocardium from cine in hypertrophic cardiomyopathy.机器学习对肥厚型心肌病电影中的瘢痕心肌进行表型分析。
Eur Heart J Cardiovasc Imaging. 2022 Mar 22;23(4):532-542. doi: 10.1093/ehjci/jeab056.
6
Different Phenotypes of Anderson-Fabry Disease Identified with Cardiac Magnetic Resonance Imaging in a Family with the Same Late-Onset Mutation.心脏磁共振成像在一个具有相同迟发性突变的家系中鉴定出不同表型的安德森-法布里病。
Am J Case Rep. 2020 Oct 29;21:e925631. doi: 10.12659/AJCR.925631.
7
The Advantages of New Multimodality Imaging in Choosing the Optimal Management Strategy for Patients with Hypertrophic Cardiomyopathy.新型多模态成像在肥厚型心肌病患者最佳治疗策略选择中的优势
Diagnostics (Basel). 2020 Sep 19;10(9):719. doi: 10.3390/diagnostics10090719.
8
Cardiac magnetic resonance imaging in the evaluation of patients with hypertrophic cardiomyopathy.心脏磁共振成像在肥厚型心肌病患者评估中的应用
Glob Cardiol Sci Pract. 2018 Aug 12;2018(3):22. doi: 10.21542/gcsp.2018.22.
9
Rest perfusion abnormalities in hypertrophic cardiomyopathy: correlation with myocardial fibrosis and risk factors for sudden cardiac death.肥厚型心肌病中的静息灌注异常:与心肌纤维化及心源性猝死危险因素的相关性
Clin Radiol. 2015 May;70(5):495-501. doi: 10.1016/j.crad.2014.12.018. Epub 2015 Feb 7.
10
The role of echocardiography in hypertrophic cardiomyopathy.超声心动图在肥厚型心肌病中的作用。
Curr Cardiol Rep. 2015 Feb;17(2):6. doi: 10.1007/s11886-014-0560-x.